bortezomib,dexamethasone,lenalidomide
takeda
['multiple myeloma', 'determination']
 determination confirms the value of upfront autologous stem cell transplantation for patients with newly diagnosed multiple myeloma with unprecedented progression-free survival results. #asco22 
Levine Cancer Institute is home to top providers, cutting-edge treatments and groundbreaking clinical trials. Our expert care helps patients heal – and thrive.